Purpose: Human amniotic fluid contains multiple cell types, including pluripotent and
committed progenitor cells, and fully differentiated cells. We characterized various cell …

Objectives: The role of stem cells in regenerative medicine is evolving rapidly. Here, we
describe the application, for kidney regeneration, of a novel non‐genetically modified stem …

Amniotic fluid as a source of pluripotent and multipotent st... : Current Opinion in Organ
Transplantation Amniotic fluid as a source of pluripotent and multipotent stem cells for organ …

Although dialysis and transplantation are widely applied therapies for renal failure,
drawbacks such as morbidity, shortage of compatible organs and high cost are limiting …

Over the past decade, there has been ever‐increasing emphasis placed on stem cells and
their potential role in regenerative medicine for reconstruction of bio‐artificial tissues and …

The in vitro derivation of renal lineage progenitor cells is essential for renal cell therapy and
regeneration. Despite extensive studies in the past, a protocol for renal lineage induction …

In humans, nephrogenesis is completed prenatally, with nephrons formed until 34 weeks of
gestational age. We hypothesized that urine of preterm neonates born before the completion …

Renal cells are used in basic research, disease models, tissue engineering, drug screening,
and in vitro toxicology. In order to provide a reliable source of human renal cells, we …

During nephrogenesis, stem/progenitor cells differentiate and give rise to early nephron
structures that segment to proximal and distal nephron cell types. Previously, we …

In the human fetal kidney (HFK) self-renewing stem cells residing in the metanephric
mesenchyme (MM)/blastema are induced to form all cell types of the nephron till 34th week …